Share

Networks

Clinical Studies (2)

  • STIMULATE-ICP : Study aims to evaluate the effectiveness of an integrated care pathway in improving fatigue and physical, psychological, and functional outcomes in adults with Long COVID, and to assess, through an embedded Phase III open-label platform randomised drug trial, the efficacy of candidate therapies such as rivaroxaban, colchicine, and famotidine/loratadine compared with no drug treatment
  • PHOSP-COVID : Study aims to analyse routine clinical data with linkage to retrospective and prospective health and social care records, enhanced clinical data and research-specific biosampling and re-call of participants by genotype and phenotype for more detailed studies

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Community
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition
  • Colchicine
  • Antihistamines
  • Rivaroxaban

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to